Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during October, 2025'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec Limited has submitted a routine disclosure to the stock exchange reporting the number of shares that were converted from physical (paper) certificates into electronic (demat) form during October 2025. This is a standard monthly compliance filing required under SEBI's dematerialization norms to track how many shareholders are shifting from paper shares to digital holdings. The company has not disclosed any specific share count in the headline, but the report covers all dematerialization requests processed during the month. Such filings help regulators monitor the broader shift away from physical share certificates in the Indian market.
This is a routine administrative filing with no direct impact on the company's financials, operations, or stock price. It is purely a regulatory disclosure and should not influence investment decisions.